DEUTSCHE BANK AG\ - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$66,000
-73.6%
140,817
-24.8%
0.00%
Q1 2019$250,000
-78.7%
187,222
-82.0%
0.00%
-100.0%
Q4 2018$1,174,000
+84.0%
1,040,447
+348.8%
0.00%
Q3 2018$638,000
-29.0%
231,808
-8.0%
0.00%
Q2 2018$899,000
-36.0%
252,097
-44.9%
0.00%
-100.0%
Q1 2018$1,405,000
+0.8%
457,894
+106.8%
0.00%0.0%
Q4 2017$1,394,000
+148.0%
221,425
+168.6%
0.00%
Q3 2017$562,000
-37.6%
82,429
-34.8%
0.00%
-100.0%
Q2 2017$900,000
-45.5%
126,422
-29.8%
0.00%0.0%
Q1 2017$1,652,000
+58.8%
179,964
-30.4%
0.00%0.0%
Q4 2016$1,040,000
-22.0%
258,670
-25.8%
0.00%0.0%
Q3 2016$1,333,000
-1.8%
348,433
+10.2%
0.00%0.0%
Q2 2016$1,358,000
-10.5%
316,061
-3.8%
0.00%0.0%
Q1 2016$1,518,000
+28.0%
328,468
+176.9%
0.00%0.0%
Q4 2015$1,186,000
+167.1%
118,606
+98.3%
0.00%
Q3 2015$444,000
-78.1%
59,801
+40.0%
0.00%
-100.0%
Q2 2015$2,025,000
-2.6%
42,722
-24.7%
0.00%0.0%
Q1 2015$2,079,000
+531.9%
56,765
+584.1%
0.00%
Q4 2014$329,000
-77.7%
8,298
-88.8%
0.00%
-100.0%
Q3 2014$1,478,000
+28.4%
74,173
-13.1%
0.00%0.0%
Q2 2014$1,151,000
+1727.0%
85,390
+1357.7%
0.00%
Q1 2014$63,000
+70.3%
5,858
+109.4%
0.00%
Q4 2013$37,000
-76.1%
2,797
-79.6%
0.00%
Q3 2013$155,00013,7270.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders